logo

CHRS

Coherus Oncology·NASDAQ
--
--(--)
--
--(--)
3.06 / 10
Netural

Technical rating is neutral (3.06/10). Dark Cloud Cover shows bullish strength, but five bearish signals dominate: Long Lower Shadow, RSI Overbought, MACD Death Cross, Long Upper Shadow, and Marubozu White. Market volatility is high and directional bias remains unclear.

FundamentalSentimentTechnical(3.06)

Analysis Checks(1/6)

Long Lower Shadow
Score1.14/10
Win Rate41.86%
Hist. Signals43
Avg Return-1.28%
Long Upper Shadow
Score2.15/10
Win Rate44.78%
Hist. Signals67
Avg Return-0.13%
RSI Overbought
Score1/10
Win Rate13.33%
Hist. Signals15
Avg Return-6.25%
MACD Death Cross
Score2.79/10
Win Rate40.00%
Hist. Signals10
Avg Return1.25%
Dark Cloud Cover
Score7.7/10
Win Rate66.67%
Hist. Signals6
Avg Return5.92%
Marubozu White
Score3.58/10
Win Rate45.00%
Hist. Signals20
Avg Return2.29%
What is the current technical signals for CHRS?
  • CHRS presents a Netural setup with a Technical Score of 3.06/10. Key technical indicators highlight an RSI of 52.78 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 1.83. Traders should monitor key support at 1.63 and resistance at 1.77.